Actorius Innovations and Research

From Cell to Certainty

[Actorius Innovations and Research @Actorius_IR]

Kidney cancer monitoring is evolving beyond imaging. OncoDiscover, a blood-based liquid biopsy test, detects circulating tumor cells (CTCs) to support treatment monitoring and long-term care. Early detection matters. #WorldKidneyCancerDay #KidneyCancerAwareness #LiquidBiopsy

[Actorius Innovations and Research @Actorius_IR]

“The deadliest cancer threat may be invisible; just one surviving cell can restart the journey.”
At Actorius Innovations & Research, Dr. Jayant Khandare and team are advancing CTC, liquid biopsy & MRD research through OncoDiscover®️ to support earlier cancer insights.
#cancerfree

[Actorius Innovations and Research @Actorius_IR]

Early detection and smarter monitoring are changing cancer care. OncoDiscover, a blood-based liquid biopsy test, helps monitor cancer by detecting circulating tumor cells (CTCs), supporting treatment follow-up and long-term care in melanoma & skin cancers. #SkinCancerAwareness

[Actorius Innovations and Research @Actorius_IR]

We were honored to share the stage with renowned Surgical Oncologists from Chennai at the Chennai City Surgical Oncology Meet (TASO). @Dr_JayantK spoke on the clinical utility of CTCs, metastasis, recurrence risk & OncoDiscover — India’s CDSCO-approved CTC test.

[Actorius Innovations and Research @Actorius_IR]

Brain tumors are difficult to monitor due to limited biopsy access and evolving disease biology. OncoDiscover uses a blood-based liquid biopsy to detect circulating tumor cells (CTCs), helping support cancer monitoring and long-term treatment follow-up. #BrainTumorAwareness

[Actorius Innovations and Research @Actorius_IR]

Cancer care doesn’t stop at treatment. Even after CR & NED, relapse risk can remain hidden.

OncoDiscover® uses a simple blood test to monitor circulating tumor cells (CTCs), helping detect residual disease and relapse risk earlier for proactive cancer care.

#OncoDiscover #CTC

[Actorius Innovations and Research @Actorius_IR]

We’re excited to share that at @ASCO Annual Meeting 2026 , we have published 3 abstracts highlighting the advancing role of circulating tumor cells (CTCs) in cancer biology & precision oncology.

To know more: https://t.co/TrMVjFigRz

#ASCO #Actorius @Dr_JayantK @aravasudevan

[Actorius Innovations and Research @Actorius_IR]

Bladder cancer requires long-term monitoring due to high recurrence rates. OncoDiscover®, a blood-based CTC test, helps support treatment follow-up by detecting circulating tumor cells through a simple liquid biopsy approach. #BladderCancer #LiquidBiopsy #CTC #OncoDiscover

[Actorius Innovations and Research @Actorius_IR]

Cancer monitoring, made simpler. OncoDiscover® is a DCGI-approved, blood-based CTC test designed for safer, non-invasive cancer monitoring with precise clinical insights. Supporting early intervention & informed treatment decisions.
OncoDiscover
#LiquidBiopsy #CancerMonitoring

[Actorius Innovations and Research @Actorius_IR]

On #WorldOvarianCancerDay, we raise awareness about the importance of early detection & continuous monitoring. Liquid biopsy innovations like OncoDiscover help track circulating tumor cells (CTCs) through a simple blood test—supporting smarter cancer care. #Actorius #LiquidBiopsy

[Actorius Innovations and Research @Actorius_IR]

Cancer care goes beyond detection—it’s about understanding disease in real time. OncoDiscover® uses a simple blood test to track circulating tumor cells, helping clinicians monitor treatment response and detect early progression
#OncoDiscover #LiquidBiopsy #CancerMonitoring

[Actorius Innovations and Research @Actorius_IR]

@AACR Annual Meeting 2026 has been an incredible milestone for Actorius Innovations and Research.
We thank everyone who visited our posters and booth, and contributed to these valuable discussions.
@Dr_JayantK @aravasudevan

[Actorius Innovations and Research @Actorius_IR]

Dr. Yuvraj Patil – Principal Scientist, Medical Devices, Actorius Innovations and Research, presents our investigational OncoMetastat® platform and the engineering behind its approach to circulating tumor cell (CTC) capture.
#AACR2026 #CTCs #OncoMetastat #MedicalDevices

[Actorius Innovations and Research @Actorius_IR]

OncoDiscover® uses a simple blood test to identify circulating tumor cells, clusters & key biomarkers helping clinicians monitor progression and treatment response in real time.

Precision oncology starts at the cellular level.

#LiquidBiopsy #CancerCare #OncologyInnovation

[Actorius Innovations and Research @Actorius_IR]

From the floor of #AACR2026 in San Diego, @Dr_JayantK – Co-founder, MD & CSO, Actorius Innovations and Research, shares the vision behind OncoMetastat® and its potential role in shaping the future of metastasis control.
#OncologyResearch #CTC #Metastasis #Actorius #OncoMetastat

[Actorius Innovations and Research @Actorius_IR]

@Dharamshilah @NarayanaHealth @aravasudevan @Dr_JayantK

[Actorius Innovations and Research @Actorius_IR]

We had a highly insightful Tumor Board Meeting at Dharamshila Narayana Superspeciality Hospital, Delhi, focused on the clinical utility of circulating tumor cells (CTCs) across various cancers.

#TumorBoard #Oncology #CancerMonitoring #CTC #LiquidBiopsy #OncoDiscover #Actorius

[Actorius Innovations and Research @Actorius_IR]

Join us at AACR 2026.

If you’re attending AACR, let’s connect and exchange ideas shaping the next phase of oncology innovation.

📍 Visit our Booth #3958
📅 Meet: https://t.co/7hf12YfR7p

#AACR2026 #CTCs #OncologyResearch #Metastasis #OncoMetastat
@AACR @Dr_JayantK @aravasudevan

[Actorius Innovations and Research @Actorius_IR]

OncoDiscover® CTC Test India’s 1st DCGI-approved, patented liquid biopsy detects circulating tumor cells from a simple blood sample. Track treatment response, monitor progression, and enable smarter cancer care decisions with real-time insights.
#LiquidBiopsy #CancerMonitoring

[Actorius Innovations and Research @Actorius_IR]

Esophageal cancer often goes unnoticed early. Liquid biopsy helps track cancer in real time through CTCs.
OncoDiscover® is a DCGI-approved blood test supporting smarter monitoring and better treatment insights.
#EsophagealCancer #Oncology #Cancer